Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

The Toronto Stock Exchange ’s S&P/TSX composite index finished up 20.5 points or 0.1%, having sunk to begin the trading week, ...

Hims & Hers' first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid ...

Andrew Dudum; Chairman of the Board, Chief Executive Officer; Hims & Hers Health Inc Oluyemi Okupe; Chief Financial Officer; Hims & Hers Health Inc Good afternoon, ladies and gentlemen. Thank you for ...

Investors are watching closely central bank actions after chatter that the authorities were tolerating a stronger currency to win concessions from the U.S.

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results , with sales up 111% year on year to $586 ...

Hims & Hers is an increasingly profitable, vertically integrated telehealth platform with major tailwinds, positioning it as ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...